Back to Screener

Healthcare

Dianthus Therapeutics, Inc.(DNTH)

Live Price

Offline

$95.35

+4.13% today

1Y Change

+419.40%

Window

Jun 27, 2025 โ†’ Jun 25, 2026

Market Cap
$3.47B
Revenue Growth
-67.3%
EPS Growth
-64.7%
Dividend Yield
0.0%

Coverage: 250 bars ยท Jun 27, 2025 โ†’ Jun 25, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Dianthus Therapeutics, Inc. (DNTH) is a Healthcare stock with a market cap of $3.47B and listed on NASDAQ. The stock last traded around $95.35 and up 419.4% across the available one-year price window (Jun 27, 2025 โ†’ Jun 25, 2026). Baseline metrics include revenue growth of -67.3%, EPS growth of -64.7%, a dividend yield of 0.0%. What stands out right now is revenue -67.3%, EPS -64.7%, free cash flow -65.1% with operating margin -21911.7% and ROIC -15.8%. Valuation already assumes a fairly strong business story at price/sales 3970.9. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines DNTH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

DNTH vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

DNTH

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

DNTH Max Drawdown

-20.20%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for DNTH and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 11, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 11, 26
โ€”
Est -1.10
โ€”
โ€”
Est 413.6B
โ€”
May 11
โ€”
Mar 9, 26
โœ—
-1.43
Est -0.98
-45.9%
284.0B
Est 552.2B
-48.6%
Mar 9
โ€”
Nov 5, 25
โœ—
-0.97
Est -0.86
-12.8%
396.0B
Est 398.1B
-0.5%
Nov 5
โ€”
Aug 7, 25
โœ—
-0.88
Est -0.86
-2.3%
193.0B
Est 864.7B
-77.7%
Aug 7
โ€”
May 12, 25
โœ“
-0.82
Est -0.86
+4.7%
1163.0B
Est 806.9B
+44.1%
May 12
โ€”
Mar 11, 25
โœ“
-0.81
Est -0.85
+4.7%
1326.0B
Est 955.2B
+38.8%
Mar 11
โ€”
Nov 7, 24
โœ—
-0.74
Est -0.59
-25.4%
2172.0B
Est 844.1B
+157.3%
Nov 7
โ€”
Aug 8, 24
โœ—
-0.51
Est -0.50
-2.0%
1863.0B
Est 320.0B
+482.2%
Aug 8
โ€”
May 9, 24
โœ—
-0.54
Est -0.43
-25.6%
874.0B
Est 460.0B
+90.0%
May 9
โ€”
Mar 21, 24
โœ“
-0.71
Est -1.11
+36.0%
457.0B
Est 310.0B
+47.4%
Mar 21
โ€”
Nov 9, 23
โœ—
-3.78
Est -0.51
-641.2%
924.0B
Est 410.0B
+125.4%
Nov 9
โ€”
Aug 3, 23
โœ“
-0.05
Est -0.19
+73.7%
969.0B
Est โ€”
โ€”
Aug 3
โ€”
Mar 30, 23
โœ—
-7.70
Est -6.40
-20.3%
476.0B
Est โ€”
โ€”
Mar 30
โ€”
Dec 31, 22
โœ“
-2.67
Est -4.10
+34.9%
1175.0B
Est โ€”
โ€”
Dec 31
โ€”
Sep 30, 22
โœ“
-2.10
Est -4.64
+54.7%
1173.0B
Est โ€”
โ€”
Sep 30
โ€”
Aug 4, 22
โœ“
-4.70
Est -5.44
+13.6%
โ€”
Est โ€”
โ€”
Aug 4
โ€”
May 16, 22
-6.24
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
May 16
โ€”
Mar 8, 22
โœ—
-5.25
Est -5.09
-3.1%
โ€”
Est โ€”
โ€”
Mar 8
โ€”
Nov 4, 21
-4.76
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Nov 4
โ€”
Aug 5, 21
-5.04
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar